Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 132.30
+1.30 (0.99%)
At close: Jun 16, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 59.02 billion as of June 16, 2026. Its market cap has increased by 47.16% in one year.
Market Cap
59.02B
Enterprise Value
66.31B
Revenue
46.34B
Ranking
n/a
PE Ratio
9.29
Stock Price
132.30
Market Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 59.02B, an increase of 2,988.61%. That is a compound annual growth rate of 13.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 59.02B | 29.58% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 191.21B |
| Renata | 48.83B |
| Unilever Consumer Care | 39.82B |
| Beacon Pharmaceuticals | 24.16B |
| The ACME Laboratories | 16.67B |
| Asiatic Laboratories | 15.27B |
| The IBN SINA Pharmaceutical Industry | 9.79B |
| Navana Pharmaceuticals | 7.79B |